Peter Pitts, a former FDA Associate Commissioner and member of the United States Senior Executive Service, is President of the Center for Medicine in the Public Interest and a Visiting Professor at the University of Paris Medical School.
The Trump administration recently finalized two rules meant to reduce Medicare drug prices -- while ignoring some serious unintended consequences.For ...